{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T08:54:05Z","timestamp":1768812845178,"version":"3.49.0"},"reference-count":55,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2012,1,13]],"date-time":"2012-01-13T00:00:00Z","timestamp":1326412800000},"content-version":"vor","delay-in-days":12,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Cardiology"],"published-print":{"date-parts":[[2012,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This article provides an overview of (i) the risk of stroke associated with vascular disease (acute coronary syndromes and peripheral artery disease) in patients with atrial fibrillation, (ii) the frequent coexistence of vascular disease in patients with atrial fibrillation and, (iii) the cardiovascular risk associated with the coexisting of the two diseases. The literature on this topic is relatively sparse, and we discuss results from both clinical trials and observational studies.<\/jats:p><jats:p>There is a clear indication of an increased stroke risk associated with vascular disease in patients with atrial fibrillation. Indeed, patients with atrial fibrillation often had coexisting vascular disease (around 18%), and the combination of the two diseases substantially increases the risk of future cardiovascular events. The increased risk associated with peripheral artery disease in atrial fibrillation is even more pronounced.<\/jats:p><jats:p>Patients with atrial fibrillation and stable vascular disease should be treated with oral anticoagulation only, although when these patients present with acute coronary syndrome and\/or undergo coronary stenting, concomitant treatment with antiplatelet drugs is indicated. To guide antithrombotic management in patients with atrial fibrillation, several stroke and bleeding risk prediction schemes have been developed. <jats:italic>Clin. Cardiol.<\/jats:italic> 2012 DOI: 10.1002\/clc.20955<\/jats:p><jats:p>Dr. Olesen received an honorarium through an educational grant from Sanofi Aventis for time and expertise spent writing this article. Dr Lip has served as a consultant for Bayer, Astellas, Merck, AstraZeneca, Sanofi, BMS\/Pfizer, Biotronik, Portola and Boehringer Ingelheim and has been on the speakers bureau for Bayer, BMS\/Pfizer, Boehringer Ingelheim, and Sanofi\u2010Aventis. Drs. Gislason and Torp\u2010Pedersen disclose no conflicts of interest.<\/jats:p>","DOI":"10.1002\/clc.20955","type":"journal-article","created":{"date-parts":[[2012,1,13]],"date-time":"2012-01-13T19:55:51Z","timestamp":1326484551000},"source":"Crossref","is-referenced-by-count":26,"title":["Atrial Fibrillation and Vascular Disease\u2014A Bad Combination"],"prefix":"10.1002","volume":"35","author":[{"given":"Jonas","family":"Bjerring Olesen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunnar Hilmar","family":"Gislason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Torp\u2010Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,1,13]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH10-05-0332"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.02.047"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2008.06.029"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)00415-5"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2011.03.033"},{"key":"e_1_2_7_7_2","article-title":"Risk factors for stroke and thromboembolism in relation to age amongst patients with atrial fibrillation: The Loire Valley Atrial Fibrillation Project [published online ahead of print June 16, 2011]","author":"Olesen JB","journal-title":"Chest"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2011.04308.x"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.92.8.2178"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1994.00420130036007"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000267275.68538.8d"},{"key":"e_1_2_7_12_2","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/archinte.1990.00390160077016","article-title":"Risk factors for thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.","volume":"150","author":"Petersen P","year":"1990","journal-title":"Arch Intern Med."},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.8.936"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(89)90349-4"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH07-08-0508"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq278"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68845-4"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2006.06.024"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1007432"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0905561"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03510350050036"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2006.06.042"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.06.080"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000072767.89944.6E"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.659"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.06.023"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.10.946"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(98)00583-9"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0901301"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1007378"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2010.01.031"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0803778"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2011.04378.x"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d124"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi505"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1995.00430050045005"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-1584"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-0134"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.22.2864"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2005.04.017"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-12-200706190-00007"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70264-8"},{"key":"e_1_2_7_43_2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1160\/TH08-08-0499","article-title":"How effective are dose\u2010adjusted warfarin and aspirin for the prevention of stroke in patients with chronic atrial fibrillation? An analysis of the UK General Practice Research Database","volume":"101","author":"Rietbrock S","year":"2009","journal-title":"Thromb Haemost."},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH10-01-0038"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH09-10-0746"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020496"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.108.526988"},{"key":"e_1_2_7_48_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH10-10-0642"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39351.706586.AD"},{"key":"e_1_2_7_50_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2010.271"},{"key":"e_1_2_7_51_2","doi-asserted-by":"publisher","DOI":"10.1080\/07853890802089786"},{"key":"e_1_2_7_52_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH09-08-0580"},{"key":"e_1_2_7_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61751-7"},{"key":"e_1_2_7_54_2","doi-asserted-by":"publisher","DOI":"10.1177\/1753944710397225"},{"key":"e_1_2_7_55_2","article-title":"Impact of National Clinical Guideline Recommendations for Revascularization of Persistently Occluded Infarct\u2010Related Arteries on Clinical Practice in the United States [published online ahead of print July 11, 2011]","author":"Deyell MW","journal-title":"Arch Intern Med"},{"key":"e_1_2_7_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(98)00247-1"}],"container-title":["Clinical Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fclc.20955","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/clc.20955","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:17Z","timestamp":1695772817000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/clc.20955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":55,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["10.1002\/clc.20955"],"URL":"https:\/\/doi.org\/10.1002\/clc.20955","archive":["Portico"],"relation":{},"ISSN":["0160-9289","1932-8737"],"issn-type":[{"value":"0160-9289","type":"print"},{"value":"1932-8737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}